` VANI (Vivani Medical Inc) vs S&P 500 Comparison - Alpha Spread

VANI
vs
S&P 500

Over the past 12 months, VANI has underperformed S&P 500, delivering a return of -8% compared to the S&P 500's 9% growth.

Stocks Performance
VANI vs S&P 500

Loading
VANI
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
VANI vs S&P 500

Loading
VANI
S&P 500
Difference
www.alphaspread.com

Performance By Year
VANI vs S&P 500

Loading
VANI
S&P 500
Add Stock

Competitors Performance
Vivani Medical Inc vs Peers

Vivani Medical Inc
Glance View

Market Cap
68.1m USD
Industry
Health Care

Vivani Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Emeryville, California and currently employs 15 full-time employees. The company went IPO on 2014-11-19. Vivani Medical, Inc., formerly Second Sight Medical Products, Inc., is a developer of implantable visual prosthetics that creates an artificial form of useful vision for blind individuals. The firm is the combination of Nano Precision Medical, Inc. (NPM) and Second Sight Medical Products, Inc. NPM is a biopharmaceutical business that develops miniaturized, subdermal drug implants utilizing its NanoPortal technology to enable long-term, near constant-rate delivery of medicines to treat chronic diseases. Its divisions include Drug Implant & Visual Protheses division. The firm's Drug Implant division is developing a portfolio of miniature drug implants which utilize its NanoPortal drug implant technology. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. The firm's Visual Protheses division is developing implantable visual prostheses devices that are intended to deliver useful artificial vision to blind individuals.

VANI Intrinsic Value
0.22 USD
Overvaluation 81%
Intrinsic Value
Price
Back to Top